Prevalence and risk factors of symptomatic dry eye disease in Lebanon

Sherry, Ahmed; Aridi, Mona; Ghach, Wissam

doi:10.1016/j.clae.2019.08.001

Cited by 30 publications

(40 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This might be because of the high percentage of rheumatoid arthritis, DM and the use of age-related systemic and topical medications in the elderly population. 21,23,27,31,35 Alzahrani et al 21 and several other researchers (Sherry et al 35 ; Shanti et al 31 ) have reported a significant association between TF harm and increase in age (see Table 2). This may be because of the high percentage of rheumatoid arthritis, DM and the use of age-related systemic and topical medications, which may lead to deterioration of TF intact.…”

Section: Discussionmentioning

confidence: 86%

“…28 In a clinical study of an asymptomatic DE in the Lebanese population, with subjects older than 18 years, the prevalence was found to be 36.4%. 35 The symptomatic DE assessment by the OSDI questionnaire was adopted in some studies.…”

Section: Prevalence Of Dry Eyementioning

confidence: 99%

“…2 Several DEQs have been included in Arab studies, such as the OSDI questionnaire, six-item questionnaire and CVS questionnaire. 21,23,27,30,31,32,33,35,36 However, the OSDI is one of the most common tools for the diagnosis of DE syndrome and other ocular surface diseases, such as allergic conjunctivitis and blepharitis, 37 in the Arab population. This questionnaire consists of 12 items that evaluate three subscales of DE consisting of experiencing symptoms of ocular irritation in the eyes, change in functional quality of vision and environmental factor stimuli of DE.…”

Section: Clinical Diagnosis Of Dry Eyementioning

confidence: 99%

“…Increase in age Alzahrani et al 21 ; Alshamrani et al 23 ; Alharbi et al 27 ; Shanti et al 31 ; Sherry et al 35 Female gender Yasir et al 12 ; Alshamrani et al 23 ; Shanti et al 31 ; Haddad et al 36 ; Shadia et al 58 CLs uses Alsweilem et al 20 ; Sharief 37 Refractive operations and cataract operation Alsweilem et al 20 ; Alzahrani et al 23 ; Sharief 37; Kalakattawi et al 59 Glaucoma, medications, topical glaucoma eye drops and biological drugs Yasir et al 12 ; Younis and Al-Quzweeni 32 Using antidepressants drug and/or multivitamins supplements Alharbi et al 27 Acanthamoeba keratitis, pterygium, blepharitis, spring catarrh, MGD, allergic conjunctivitis and keratoconus Omran et al 17 ;Alsweilem et al 20 ;Zbiba et al 34 ; Sharief 37 ; Awad et al 60 ; El Sawy et al 61 Rheumatoid arthritis, thyroid diseases and high total cholesterol levels Alzahrani et al 21 ; Alharbi et al 27 ; Younis 32 ; Abusharaha et al 62 ; ALANAZI 63 Diabetes mellitus Alshamrani et al 23 ; Alzahrani et al 21 ; Alharbi et al 27 ; Masmali et al 64 ; Kamel et al 65 ; El Sawy et al 61 ; Kalakattawi et al 59 ; Elnour et al 66 ; Masmali et al 64 Hypertension, dyslipidaemia and obesity Safaa Bashir et al 67 ; Alghamdi 68 Wider us...…”

Section: Risk Factors Referencesmentioning

confidence: 99%

See 3 more Smart Citations

A systematic review on prevalence, risk factors, clinical diagnosis and medical management of dry eye disease in the Arab population

Aljarousha

Badarudin

Azemin

et al. 2021

African Vision and Eye Health

View full text Add to dashboard Cite

Background: Dry eye (DE) is a multifactorial disorder that can influence tear production, functional visual acuity and ultimately increase the osmolarity of the tear film. The prevalence of DE ranges from 7% to 33% across the world. However, to the best of our knowledge, the prevalence range of DE in Arab countries is not precisely documented in the literature.Aim: The aim of this article was to determine the prevalence range of DE, investigate the major risk factors of DE and identify the clinical diagnosis and medical management of DE.Method: In this study, only English language articles from 2017 to 2020 were selected. There were 52 articles on prevalence, risk factors, clinical diagnosis and medical management of DE in the Arab population.Results: The prevalence of DE in the Arab population varies in reports, from 10% in the United Arab Emirates (Dubai) to 69% in Palestine (West Bank). Gender difference (DE more in women), wearing of contact lenses, diabetes mellitus and glaucoma were all known to intensify the symptoms of DE. Lastly, there are two approaches to reduce DE in the Arab population, namely, pharmacologic and non-pharmacologic methods.Conclusion: The prevalence of DE in the Arab population was relatively high. In addition, the ocular surface disease index is one of the most common tools for the diagnosis of DE, whilst tear break-up time test is the common clinical test used in the Arab reports. Lastly, the most common treatment for DE is artificial tears.

show abstract

Section: Discussionmentioning

confidence: 86%

Section: Prevalence Of Dry Eyementioning

confidence: 99%

Section: Clinical Diagnosis Of Dry Eyementioning

confidence: 99%

Section: Risk Factors Referencesmentioning

confidence: 99%

See 2 more Smart Citations

A systematic review on prevalence, risk factors, clinical diagnosis and medical management of dry eye disease in the Arab population

Aljarousha

Badarudin

Azemin

et al. 2021

African Vision and Eye Health

View full text Add to dashboard Cite

show abstract

“…Общеизвестно, что глазная поверхность наиболее подвержена воздействию ветра, низкой относительной влажности, пониженной или повышенной температуры, УФ-излучения, загрязняющих веществ, табачного дыма и др. [47][48][49]. На начальном этапе лечения больным ССГ рекомендуется использование увлажнителей воздуха или специальных очков для увлажнения воздуха рядом с глазом.…”

Section: обзоры противовоспалительная терапия синдрома «сухого глаза»unclassified

Current treatment modalities for dry eye disease

Tatarnikova¹,

Krivosheina²

2021

Russian Journal of Clinical Ophthalmology

View full text Add to dashboard Cite

For many years, dry eye disease (DED) is a common ophthalmic condition associated with ocular surface damage and loss of homeostasis of the tear film. The key pathogenic factors of DED are tear film instability and tear hyperosmolarity, ocular surface inflammation and damage, and neurosensory alterations. Current treatment for DED consists of non-medical therapies, tear substitutes, anti-inflammatory agents, and surgical procedures. These treatments improve disease course and quality of life. However, these treatments are largely palliative as long-term (and even life-long) installation of eye drops is required. Modern and effective treatments for DED are needed. This paper reviews domestic and foreign published data on the important therapies for DED and novel tools to promote symptom relief. These data are required for the understanding of the pharmacological effects of various drug classes prescribed for DED and early treatment initiation. Keywords: dry eye disease, tear replacement therapy, anti-inflammatory treatment, surgery, hyaluronic acid, preservatives. For citation: Tatarnikova E.B., Krivosheina O.I. Current treatment modalities for dry eye disease. Russian Journal of Clinical Ophthalmology. 2021;21(1):18–23. DOI: 10.32364/2311-7729-2021-21-1-18-23.

show abstract